UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Joshua Zaritsky, MD, PhD

Print
Email

Joshua Zaritsky, MD, PhD

UCLA Physician Joshua Zaritsky, MD, PhD specializes in Pediatric Nephrology, Pediatrics.
Specialty
Pediatric Nephrology, Pediatrics
Gender
Male
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License Number
A86925
Contact
(310) 825-0867 Information and referral
Email Address
jzaritsky@mednet.ucla.edu
PRACTICE LOCATION
UCLA Children's Health Center
200 UCLA Medical Plaza, Suite 265
Los Angeles, CA 90095
MEDICAL BOARD CERTIFICATION
Pediatric Nephrology, American Board of Pediatrics, 2008
Pediatrics, American Board of Pediatrics, 2004, 2012
EDUCATION
Fellowship
Pediatric Nephrology, UCLA School of Medicine, 2004 - 2007
Residency
Pediatrics, Children's Hospital, 2002 - 2004
Internship
Pediatrics, Children's Hospital, 2001 - 2002
Medical Degree
MD, Stanford University School of Medicine, 2001
AFFILIATION
Department Affiliation
Physician, Pediatric Nephrology, Hemodialysis and Peritoneal Dialysis Service, Renal Transplantation Service
MORE INFORMATION
Research Interest
Anemia and disordered iron metabolism in the setting of kidney disease; Bone and mineral metabolism.
Publications

Peer Reviewed Articles:

  1. Michel S, Geusz ME, Zaritsky JJ, Block GD. Circadian rhythm in membrane conductance expressed in isolated neurons. Science 1993 Jan 8; 259(5092): 239-41
  2. Michel S, Manivannan K, Zaritsky JJ, Block GD. A delayed rectifier current is modulated by the circadian pacemaker in Bulla. J Biol Rhythms 1999 Apr; 14(2): 141-50
  3. Zaritsky JJ, Eckman D, Wellman G, Schwarz TL, Nelson, MT. Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K+ current in K+-mediated vasodilation. Circulation Research 2000 Jul 21; 87(2): 160-166
  4. Zaritsky JJ, Schwarz TL. The consequences of removing cardiac IK1 as revealed by the targeted disruption of the murine Kir2.1 and Kir2.2 genes. Journal of Physiology 2001 Jun 15; 533(Pt3): 697-710
  5. Zaritsky JJ, Salusky IB, Atkinson J, Brandt ML, Goldstein SL. Vascular Access Complications in Long-Term Pediatric Hemodialysis Patients. Pediatr Nephrol 2008 Nov;23(11):2061-5
  6. Zaritsky JJ, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB: Hepcidin- a Potential Novel Biomarker for Iron Status in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2009 Jun;4(6):1051-6.
  7. Amin N, Gonzalez E, Lieber M, Salusky IB, Zaritsky JJ: Successful Treatment of Calcific Uremic Arteriolopathy in a Pediatric Dialysis Patient. Pediatr Nephrol. 2010 Feb:25(2): 357-362
  8. Gonzalez E, Schomberg RD, Amin N, Salusky IB, Zaritsky JJ: Sevelamer Carbonate Increases Serum Bicarbonate in Pediatric Dialysis. Pediatr Nephrol. 2010 Feb:25(2): 373-375
  9. Zaritsky JJ, Young B, Gales B, Wang HJ, Rastogi A, Westerman M, Nemeth E, Ganz T, Salusky IB: Reduction of Serum Hepcidin by Hemodialysis in Pediatric and Adult Patients. Clin J Am Soc Nephrol. 2010 Jun;5(6):1010-4.
  10. Borzych D, Bakkaloglu S, Zaritsky JJ, Suarez A, Wong W, Ranchin B, Qi C, Szabo A, Coccia P, Harambat J, Mitu F, Warady B, Schaefer F: Defining Left Ventricular Hypertrophy in Children on Peritoneal Dialysis. Clin J Am Soc Nephrol. 2011 Aug;6(8):1934-43
  11. Wesseling-Perry K, Pereira R, Elashoff R, Zaritsky JJ, Sahney S, Gales B, Jüppner H, Salusky I: Abnormalities in Skeletal Mineralization and increased Fibroblast Growth Factor 23 levels: Early Manifestations of Pediatric Renal Osteodystrophy. In Press CJASN September 2011
  12. Lukowsky LR, Molnar MR, Zaritsky JJ, Sim JS, Mucsi I, Kovesdy CP, Kalantar-Zadeh K: Mineral and Bone Disorders and Survival in Hemodialysis Patients with and without Polycystic Kidney Disease.

In Press NDT Nov 2011 Book Chapters:

  1. Amin N, Zaritsky JJ: Hematuria, Proteniuria and the Evaluation of Acute and Chronic. Pediatric Decision Making 5th Edition. Ed: Berman, S 2011
  2. Zaritsky JJ, Yorgin P: Management of Renal Anemia. Pediatric Dialysis 2nd Edition. Ed Warady BA, Schafer FS, Fine RN, Alexander SR In Press
  3. Zaritsky JJ, Warady B: Peritoneal Dialysis in the newborn: Kidney and Urinary Tract Diseases in the Neonate. Ed Kiessling S, Chishti A, Alam S

In Press Reviews:

  1. Zaritsky JJ, Young B: Hepcidin for Clinicians. Clin J Am Soc Nephrol. 2009 Aug;4(8):1384-7
  2. Zaritsky JJ, Salusky IB: Ironing Out the Phosphorus Problem Kidney Int. 2010 May;77(10):897-903.
  3. Zaritsky JJ, Warady B: Peritoneal Dialysis in Infants and Young Children. Semin Nephrol. 2011 Mar;31(2):213-24

Letters to the Editor:

  1. Zaritsky JJ, Young B: The Utility of Multivariate Analysis in the Study of Hepcidin.Kidney Int. 2009 Oct;76(8):912
Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Dr. Joshua Zaritsky,  click here to update your profile.